Global Escitalopram Oxalate API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Escitalopram Oxalate API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
Escitalopram Oxalate API report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Escitalopram Oxalate API market is projected to reach US$ 103.4 million in 2034, increasing from US$ 64 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2034. Demand from Depression Drug and Anxiety Drug are the major drivers for the industry.
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy's, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Escitalopram Oxalate API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
Depression Drug
Anxiety Drug
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Escitalopram Oxalate API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Escitalopram Oxalate API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Escitalopram Oxalate API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Escitalopram Oxalate API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Escitalopram Oxalate API introduction, etc. Escitalopram Oxalate API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Escitalopram Oxalate API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
Escitalopram Oxalate API report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Escitalopram Oxalate API market is projected to reach US$ 103.4 million in 2034, increasing from US$ 64 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2034. Demand from Depression Drug and Anxiety Drug are the major drivers for the industry.
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy's, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Escitalopram Oxalate API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
Segment by Application
Depression Drug
Anxiety Drug
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Escitalopram Oxalate API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Escitalopram Oxalate API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Escitalopram Oxalate API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Escitalopram Oxalate API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Escitalopram Oxalate API introduction, etc. Escitalopram Oxalate API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Escitalopram Oxalate API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices